153 related articles for article (PubMed ID: 2558539)
1. Reduction of ara-C cytotoxicity in HL 60 cells by addition of deoxycytidine, cytidine or increased level of cytidine deaminase.
Mejer J; Mortensen BT
Adv Exp Med Biol; 1989; 253B():335-9. PubMed ID: 2558539
[No Abstract] [Full Text] [Related]
2. Modulation of the effect of 1-beta-D-arabinofuranosylcytosine based on changes of cytidine deaminase activity in HL60 cells.
Mejer JN; Mortensen BT; Christensen IJ
Med Oncol Tumor Pharmacother; 1990; 7(1):25-9. PubMed ID: 2338846
[TBL] [Abstract][Full Text] [Related]
3. Effect of tetrahydrouridine and deoxytetrahydrouridine on the interaction between 2'-deoxycytidine and 1-beta-D-arabinofuranosylcytosine in human leukemia cells.
Grant S; Bhalla K; McCrady C
Leuk Res; 1991; 15(4):205-13. PubMed ID: 2030601
[TBL] [Abstract][Full Text] [Related]
4. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
Bhalla K; Nayak R; Grant S
Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
[TBL] [Abstract][Full Text] [Related]
6. Deoxycytidine kinase and deoxycytidine deaminase values correspond closely to clinical response to cytosine arabinoside remission induction therapy in patients with acute myelogenous leukemia.
Colly LP; Peters WG; Richel D; Arentsen-Honders MW; Starrenburg CW; Willemze R
Semin Oncol; 1987 Jun; 14(2 Suppl 1):257-61. PubMed ID: 3035720
[TBL] [Abstract][Full Text] [Related]
7. Studies on mechanisms of resistance to cytosine arabinoside: problems in the determination of related enzyme activities in leukemic cells.
Coleman CN; Johns DG; Chabner BA
Ann N Y Acad Sci; 1975 Aug; 255():247-51. PubMed ID: 171992
[No Abstract] [Full Text] [Related]
8. Decreased resistance to gemcitabine (2',2'-difluorodeoxycitidine) of cytosine arabinoside-resistant myeloblastic murine and rat leukemia cell lines: role of altered activity and substrate specificity of deoxycytidine kinase.
Bergman AM; Pinedo HM; Jongsma AP; Brouwer M; Ruiz van Haperen VW; Veerman G; Leyva A; Eriksson S; Peters GJ
Biochem Pharmacol; 1999 Feb; 57(4):397-406. PubMed ID: 9933028
[TBL] [Abstract][Full Text] [Related]
9. The role of deoxycytidine-metabolizing enzymes in the cytotoxicity induced by 3'-amino-2',3'-dideoxycytidine and cytosine arabinoside.
Mancini WR
Cancer Chemother Pharmacol; 1992; 30(2):139-44. PubMed ID: 1318170
[TBL] [Abstract][Full Text] [Related]
10. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
11. Mechanism for ara-CTP catabolism in human leukemic cells and effect of deaminase inhibitors on this process.
Fridland A; Verhoef V
Semin Oncol; 1987 Jun; 14(2 Suppl 1):262-8. PubMed ID: 3035721
[No Abstract] [Full Text] [Related]
12. The impact of selected nucleosides on the cytotoxicity of Ara-C in HL60 cells.
Mejer J
Adv Exp Med Biol; 1991; 309A():97-100. PubMed ID: 1789277
[No Abstract] [Full Text] [Related]
13. Analysis of cytidine deaminase and tetrahydrouridine interaction by use of ligand techniques.
Stoller RG; Myers CE; Chabner BA
Biochem Pharmacol; 1978 Jan; 27(1):53-9. PubMed ID: 619907
[No Abstract] [Full Text] [Related]
14. Human immunodeficiency virus type 1 induces 1-beta-D-arabinofuranosylcytosine resistance in human H9 cell line.
Yusa K; Oh-hara T; Tsukahara S; Tsuruo T
J Biol Chem; 1992 Aug; 267(24):16848-50. PubMed ID: 1512227
[TBL] [Abstract][Full Text] [Related]
15. Deoxycytidine transport in the presence of a cytidine deaminase inhibitor and the transport of uracil in Escherichia coli B.
von Dippe PJ; Leung K; Roy-Burman S; Visser DW
J Biol Chem; 1975 May; 250(10):3666-71. PubMed ID: 1092677
[TBL] [Abstract][Full Text] [Related]
16. Enzymology of cytosine arabinoside.
Cheng YC; Capizzi RL
Med Pediatr Oncol; 1982; 10 Suppl 1():27-31. PubMed ID: 7162464
[No Abstract] [Full Text] [Related]
17. In vivo development of cytosine arabinoside resistance in the BN acute myelocytic leukemia.
Hagenbeek A; Martens AC; Colly LP
Semin Oncol; 1987 Jun; 14(2 Suppl 1):202-6. PubMed ID: 3473677
[TBL] [Abstract][Full Text] [Related]
18. Hemin enhances the sensitivity of erythroleukemia cells to 1-beta-D-arabinofuranosylcytosine by both activation of deoxycytidine kinase and reduction of cytidine deaminase activity.
Honma Y; Onozuka Y; Okabe-Kado J; Kasukabe T; Hozumi M
Cancer Res; 1991 Sep; 51(17):4535-8. PubMed ID: 1873797
[TBL] [Abstract][Full Text] [Related]
19. Effect of tetrahydrouridine on metabolism and transport of 1-beta-D-arabinofuranosylcytosine in human cells.
Riva C; Barra Y; Carcassonne Y; Cano JP; Rustum Y
Chemotherapy; 1992; 38(5):358-66. PubMed ID: 1286578
[TBL] [Abstract][Full Text] [Related]
20. Kinetics and substrate specificity of human and canine cytidine deaminase.
Fanucchi MP; Watanabe KA; Fox JJ; Chou TC
Biochem Pharmacol; 1986 Apr; 35(7):1199-201. PubMed ID: 3964296
[No Abstract] [Full Text] [Related]
[Next] [New Search]
